Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine
NCT01309269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1083
Last updated 2016-11-02
Summary
This observational study will assess the effect of long-term treatment with Mircera (methoxy polyethylene glycol-epoetin beta) in chronic kidney disease patients with renal anemia. Data will be collected from each patient for at least 24 months.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- Germany
Study Locations
More Related Trials
-
A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis
NCT01892202 ·Status: NO_LONGER_AVAILABLE
-
A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia
NCT00605293 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis
NCT00559637 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia
NCT00699348 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant
NCT02538107 ·Status: COMPLETED
-
A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
NCT00550680 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
NCT01690455 ·Status: COMPLETED
-
A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
NCT00922610 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
NCT01677767 ·Status: COMPLETED
-
OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis
NCT01902628 ·Status: COMPLETED
-
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
NCT00048035 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NCT00081471 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
NCT00559273 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
NCT00642967 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
NCT00737464 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia
NCT01156363 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
NCT00364832 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis
NCT00922116 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
NCT00077597 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia
NCT01342640 ·Status: COMPLETED ·Phase: PHASE4
-
Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
NCT03552393 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
NCT00560547 ·Status: WITHDRAWN ·Phase: PHASE3
-
Observational Study of MIRCERA in Users of Self-Application and Multidose Systems
NCT02540213 ·Status: COMPLETED
-
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)
NCT01213485 ·Status: COMPLETED
-
An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis
NCT01940484 ·Status: COMPLETED